Literature DB >> 2513186

Carbohydrate structure of recombinant human uterine tissue plasminogen activator expressed in mouse epithelial cells.

G Pfeiffer1, M Schmidt, K H Strube, R Geyer.   

Abstract

Recombinant human uterine tissue plasminogen activator (tPA), in part metabolically labeled with [6-3H]glucosamine or [35S]sulfate, was isolated from mouse epithelial cells (C127). Oligosaccharides present were liberated by treatment of tryptic glycopeptides with endo-beta-N-acetylglucosaminidase H or peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase F and fractionated by high-performance liquid chromatography. The glycans were characterized by digestion with exoglycosidases, methylation analysis and, in part, by acetolysis and 1H-NMR spectroscopy. Glycopeptides comprising individual glycosylation sites were identified by N-terminal amino acid sequencing. The results demonstrate that recombinant tPA from C127 cells carries at Asn117 oligomannosidic glycans with 5-8 mannose residues as well as small amounts of hybrid-type species. Asn184 is only partially glycosylated and substituted by fucosylated triantennary and small amounts of diantennary N-acetyllactosaminic glycans. Likewise, Asn448 carries predominantly fucosylated triantennary species, in addition to, small amounts of diantennary and tetraantennary oligosaccharides. As a characteristic feature, part of the triantennary glycans at Asn184 and Asn448 contain additional Gal(alpha 1-3) substituents and/or sulfate groups linked to position six of beta-galactosyl residues forming NeuAc(alpha 2-3)[HO3S-6]Gal(beta 1-4) units. Oligosaccharides attached to Asn448 are almost completely substituted by (alpha 2-3)- or (alpha 2-6)-linked sialic acid residues and carry the majority of sulfate groups present. Glycans at Asn184 were found to be less sialylated and sulfated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2513186     DOI: 10.1111/j.1432-1033.1989.tb15206.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Host-cell-specific glycosylation of HIV-2 envelope glycoprotein.

Authors:  S Liedtke; R Geyer; H Geyer
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

Review 2.  The plasmin-antiplasmin system: structural and functional aspects.

Authors:  Johann Schaller; Simon S Gerber
Journal:  Cell Mol Life Sci       Date:  2010-12-07       Impact factor: 9.261

3.  Glycosylation of glycoprotein 55 encoded by the anaemia-inducing strain of Friend spleen focus-forming virus.

Authors:  J Völker; H Geyer; R Geyer
Journal:  Glycoconj J       Date:  1994-04       Impact factor: 2.916

4.  Glycosylation of the thrombin-like serine protease ancrod from Agkistrodon rhodostoma venom. Oligosaccharide substitution pattern at each N-glycosylation site.

Authors:  G Pfeiffer; D Linder; K H Strube; R Geyer
Journal:  Glycoconj J       Date:  1993-06       Impact factor: 2.916

5.  An HPLC-MALDI MS method for N-glycan analyses using smaller size samples: application to monitor glycan modulation by medium conditions.

Authors:  Michael P Gillmeister; Noboru Tomiya; Scott J Jacobia; Yuan C Lee; Stephen F Gorfien; Michael J Betenbaugh
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

Review 6.  Analysis of protein glycosylation by mass spectrometry.

Authors:  B Nilsson
Journal:  Mol Biotechnol       Date:  1994-12       Impact factor: 2.695

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.